Hospital
Sutter Coast Hospital
Sutter Coast Hospital was paid $21.67M by Medicaid between Jan 2018 and Nov 2024, across 205 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 19% of everything it billed.
33Billing provider infoSUTTER COAST HOSPITAL
CRESCENT CITY, CA 95531
CRESCENT CITY, CA 95531
33aNPI1457367062assigned 08/01/2006
33bProvider typeRehabilitation Hospital Unit
28Total paid$21.67M
24GClaims400,726
24DCodes billed205
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rehabilitation Hospital Unit providers in California
Rank by total paid#6 of 22
Median peer was paid$308K
This provider vs. median70×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,370 | $2.79M | |
| 2019 | 58,308 | $2.71M | |
| 2020 | 58,108 | $2.95M | |
| 2021 | 63,246 | $3.71M | |
| 2022 | 70,363 | $4.07M | |
| 2023 | 52,565 | $3.00M | |
| 2024incomplete | 39,766 | $2.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 19% | 25,210 | 21,383 | $4.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 42,246 | 32,755 | $3.81M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.7% | 2,205 | 2,152 | $1.45M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.1% | 4,852 | 2,339 | $893K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 2,280 | 2,215 | $886K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.4% | 6,034 | 5,331 | $735K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.0% | 3,942 | 2,716 | $654K |
| 99201 | 2.8% | 4,305 | 2,013 | $613K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.6% | 5,909 | 4,776 | $560K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.1% | 5,947 | 5,406 | $451K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 4,817 | 3,905 | $408K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 6,750 | 6,178 | $393K |
193 more codes
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.3% | 1,196 | $286K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 5,528 | $279K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 976 | $278K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.2% | 1,671 | $251K |
| 80053 | Comprehensive metabolic panel | 1.1% | 25,126 | $247K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.1% | 303 | $243K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 4,139 | $233K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 3,500 | $224K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,517 | $211K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,629 | $205K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 28,195 | $197K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,339 | $186K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,498 | $177K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 649 | $165K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,381 | $159K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 994 | $139K |
| J3490 | Unclassified drugs | <1% | 23,135 | $137K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 869 | $123K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 246 | $116K |
| 73630 | <1% | 1,864 | $102K | |
| 73610 | <1% | 1,544 | $93K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 484 | $93K |
| 73030 | <1% | 1,548 | $93K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,103 | $81K |
| 73130 | <1% | 1,291 | $78K | |
| 72100 | <1% | 1,222 | $77K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,356 | $74K |
| 73110 | <1% | 1,164 | $69K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 235 | $66K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,013 | $62K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,746 | $62K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,728 | $61K |
| 73562 | <1% | 1,087 | $60K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,578 | $54K |
| 82077 | <1% | 1,704 | $51K | |
| 76830 | Ultrasound, transvaginal | <1% | 342 | $51K |
| 84484 | <1% | 5,051 | $47K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 53 | $47K |
| 83880 | <1% | 1,666 | $47K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,172 | $45K |
| 81001 | <1% | 10,399 | $44K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,945 | $44K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,317 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 628 | $38K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 376 | $36K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 68 | $36K |
| 76536 | <1% | 284 | $36K | |
| 80061 | Lipid panel | <1% | 3,503 | $35K |
| 83605 | <1% | 3,341 | $35K | |
| 83690 | <1% | 5,234 | $34K | |
| 87040 | <1% | 3,191 | $33K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,738 | $32K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 57 | $30K |
| 97750 | <1% | 221 | $28K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,445 | $26K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,693 | $26K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,844 | $25K |
| 97010 | <1% | 408 | $24K | |
| 90715 | <1% | 454 | $24K | |
| 87186 | <1% | 2,411 | $23K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 938 | $22K |
| 87081 | <1% | 2,806 | $22K | |
| 87799 | <1% | 218 | $21K | |
| 87077 | <1% | 2,292 | $21K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 917 | $20K |
| 73502 | <1% | 356 | $20K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 153 | $20K |
| 76770 | <1% | 138 | $19K | |
| 81025 | <1% | 5,322 | $19K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,699 | $19K |
| 85610 | <1% | 3,243 | $18K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,350 | $17K |
| 99284 | Emergency room visit (serious) | <1% | 64 | $17K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,162 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,782 | $16K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,082 | $16K |
| 97139 | <1% | 365 | $16K | |
| 81003 | <1% | 6,107 | $16K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,661 | $16K |
| 96367 | <1% | 158 | $16K | |
| 73221 | <1% | 26 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,910 | $16K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 415 | $15K |
| 72040 | <1% | 292 | $15K | |
| 80143 | <1% | 737 | $15K | |
| 87400 | <1% | 1,479 | $14K | |
| 12001 | <1% | 103 | $14K | |
| 83735 | <1% | 2,281 | $13K | |
| 80179 | <1% | 703 | $13K | |
| 84439 | <1% | 1,706 | $13K | |
| 85730 | <1% | 1,594 | $13K | |
| 73080 | <1% | 152 | $13K | |
| 87070 | <1% | 1,253 | $12K | |
| 73140 | <1% | 302 | $12K | |
| 87631 | <1% | 181 | $11K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,812 | $11K |
| 82947 | <1% | 2,013 | $11K | |
| 87430 | <1% | 732 | $9K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,256 | $7K |
| 86900 | <1% | 578 | $7K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,181 | $7K |
| 86140 | <1% | 1,635 | $7K | |
| 93971 | <1% | 25 | $7K | |
| 72141 | <1% | 12 | $6K | |
| 72110 | <1% | 54 | $6K | |
| 0450 | Emergency room services | <1% | 104 | $6K |
| 87486 | <1% | 230 | $6K | |
| 87581 | <1% | 230 | $5K | |
| 86901 | <1% | 530 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 926 | $5K |
| 87481 | <1% | 163 | $5K | |
| 87634 | <1% | 104 | $5K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 590 | $5K |
| 99070 | <1% | 324 | $5K | |
| 80055 | <1% | 167 | $5K | |
| 87147 | <1% | 793 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 162 | $5K |
| 74018 | <1% | 132 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 24 | $5K |
| 83540 | <1% | 939 | $4K | |
| 87512 | <1% | 114 | $4K | |
| 82728 | <1% | 452 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 105 | $4K |
| 85027 | <1% | 674 | $4K | |
| 86803 | <1% | 317 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 512 | $4K |
| 83550 | <1% | 668 | $4K | |
| 73564 | <1% | 57 | $4K | |
| 85379 | <1% | 425 | $3K | |
| 70486 | <1% | 15 | $3K | |
| 85651 | <1% | 1,427 | $3K | |
| 86850 | <1% | 181 | $3K | |
| 73560 | <1% | 75 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 25 | $3K |
| 86592 | <1% | 714 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 14 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 109 | $3K |
| 87420 | <1% | 580 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $2K |
| Z9725 | <1% | 54 | $2K | |
| 87075 | <1% | 227 | $2K | |
| 87205 | <1% | 454 | $2K | |
| 94060 | <1% | 13 | $2K | |
| 94729 | <1% | 12 | $2K | |
| 94726 | <1% | 13 | $2K | |
| 80074 | <1% | 47 | $2K | |
| 73090 | <1% | 28 | $2K | |
| 76642 | <1% | 12 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 24 | $1K |
| 81329 | <1% | 12 | $1K | |
| 82746 | <1% | 133 | $1K | |
| 74022 | <1% | 16 | $1K | |
| 83655 | <1% | 170 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 114 | $1K |
| 83021 | <1% | 146 | $1K | |
| 82803 | <1% | 101 | $1K | |
| 86038 | <1% | 105 | $986.82 | |
| 82550 | <1% | 138 | $804.51 | |
| 82570 | <1% | 168 | $764.67 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 71 | $613.30 |
| 82274 | <1% | 41 | $580.32 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 80 | $569.30 |
| 73120 | <1% | 13 | $547.09 | |
| 84403 | <1% | 26 | $539.64 | |
| Z7502 | <1% | 13 | $520.80 | |
| 84100 | <1% | 134 | $424.62 | |
| 73590 | <1% | 14 | $358.50 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 38 | $315.12 |
| 82950 | <1% | 72 | $314.29 | |
| 85041 | <1% | 121 | $311.89 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 28 | $294.11 |
| 85014 | <1% | 144 | $291.21 | |
| 82670 | <1% | 13 | $290.55 | |
| 85018 | <1% | 131 | $252.28 | |
| 84481 | <1% | 14 | $194.61 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 33 | $177.78 |
| 83615 | <1% | 35 | $153.98 | |
| 84702 | <1% | 16 | $148.26 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34 | $140.40 |
| 82784 | <1% | 17 | $121.60 | |
| 82607 | <1% | 14 | $106.60 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 13 | $97.66 |
| 87088 | <1% | 14 | $85.12 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 15 | $74.90 |
| 87210 | <1% | 14 | $73.55 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 53 | $63.00 |
| 82247 | <1% | 17 | $55.59 | |
| 84550 | <1% | 15 | $44.94 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 186 | $37.65 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 35 | $28.90 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 59 | $21.13 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 165 | $12.61 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 13 | $0.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTERRA, PAIGE (CFO AND VP OF FINANCE SH VALLEY ARE)
Parent organizationSUTTER COAST HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Sutter Valley Hospitals | Modesto, CA | $76.21M |
| Sutter Valley Hospitals | Los Banos, CA | $26.09M |
| Sutter Valley Hospitals | Tracy, CA | $19.42M |
| Sutter Valley Hospitals | Los Banos, CA | $17.26M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.